Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
42.99Prev. Close
41.11Volume
2,021Total traded value
0.01 CrUpper Circuit
43.05Lower Circuit
38.95Fundamentals
| Market Cap | ₹59Cr |
| ROE | 1.59% |
| P/E Ratio(TTM) | 53.39 |
| EPS(TTM) | 0.77 |
| P/B Ratio | 2.29 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.19 |
| Book Value | 17.99 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Bacil Pharma
Bacil Pharma Limited is a public company whose main objective is to operate in the pharmaceutical business, though it is currently not undertaking any activities. The management is currently looking for the right opportunity to make the company operational and is considering diversification to drive future growth. As of March 31, 2024, the company maintained a paid-up equity capital of ₹5.89 crores to support its structure.;
| Parent Organisation | Bacil Pharma Limited |
| BSE Symbol | 524516 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 76.19 | ||
| Neuland Laboratories | NA (0.00%) | 118.64 | ||
| Jubilant Pharmova | NA (0.00%) | 37.61 | ||
| Acutaas Chemicals | NA (0.00%) | 59.72 |